Davis Matthew W. Insider Trading -- Recent SEC Form 4 Transactions
Davis Matthew W. (CIK 2094283) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-16). Recent activity: Sell AQST (7,197 shares), Sell AQST (5,303 shares), Buy AQST (50,000 shares), Buy AQST (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-16 | Aquestive Therapeutics, Inc. (AQST) | Chief Development Officer | Sell | 7,197 | $25,526 |
| 2026-11-12 | Aquestive Therapeutics, Inc. (AQST) | Chief Development Officer | Sell | 5,303 | $18,667 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Development Officer | Buy | 50,000 | $0 |
| 2025-11-12 | Aquestive Therapeutics, Inc. (AQST) | Chief Development Officer | Buy | 50,000 | $0 |
Source: SEC Form 4 filings · as of 2026-11-16